Can Fish Oil Raise Cholesterol?

Fish oil can raise LDL cholesterol, and in some people the increase is clinically meaningful. This effect shows up most reliably in individuals who start with elevated triglycerides, and it stems from how the body processes the fats that fish oil clears from the bloodstream. The story is more nuanced than a simple yes or no, though, because the type of omega-3 fatty acid matters, the size of the LDL particles that increase may matter even more, and your genetic background can amplify or mute the whole effect.

What Happens to Triglycerides and LDL at the Same Time

Fish oil’s best-documented lipid effect is lowering triglycerides. The American Heart Association recommends prescription omega-3 fatty acids at doses of two to four grams per day specifically for people with elevated triglycerides.¹ That triglyceride-lowering power is what attracts most users. But the same biochemical process that drives triglycerides down can push LDL cholesterol up, and this side effect has been documented in clinical trials for decades.

In a placebo-controlled trial of people with high triglycerides, fish oil dropped plasma triglycerides substantially but raised LDL cholesterol, raised apolipoprotein B (the protein that rides on each LDL particle), and worsened the ratio of LDL to HDL cholesterol.² This isn’t some freak finding from one study. It has been replicated enough times that clinicians who prescribe high-dose omega-3s for triglyceride management routinely monitor LDL levels afterward.

Why Fish Oil Pushes LDL Up

The mechanism traces back to how your liver handles fat-carrying particles. Triglycerides travel through the blood inside particles called VLDL. Omega-3 fatty acids reduce the liver’s production of these VLDL particles, which is why triglycerides fall.³ Several pathways contribute to this: omega-3s can increase the burning of fatty acids for energy, reduce the liver’s own fat production, and dial down the enzymes that assemble triglycerides.⁴

Here is where the paradox kicks in. Normally, a large share of VLDL particles get cleared from the bloodstream directly, without ever becoming LDL. But when fish oil is on board, the fraction of VLDL that converts into LDL rises dramatically. One study found that the proportion of VLDL converted to LDL jumped from about 17% to 56% during fish oil supplementation.⁵ So even though fewer VLDL particles are being produced, a much larger share of the ones that remain end up becoming LDL. Research in animal models confirmed the same pattern: VLDL concentrations fell sharply, but LDL only dropped modestly because of a threefold increase in the conversion rate.⁶

The net result depends on the balance between these two forces. If the liver produces far less VLDL, the increased conversion rate might not generate enough LDL to show up as a meaningful rise on your blood test. But in people who start with very high triglyceride levels, there’s so much VLDL raw material that even a proportionally smaller pool still feeds plenty of new LDL into the bloodstream.

DHA Raises LDL More Than EPA

Fish oil contains two main omega-3 fatty acids, EPA and DHA, and they don’t behave the same way when it comes to LDL. The ComparED trial, which directly compared high-dose EPA against high-dose DHA head to head, found that DHA raised LDL cholesterol by about 3.3% compared to EPA.⁷ At the same time, DHA increased mean LDL particle size and reduced the proportion of small, dense LDL particles. EPA had a milder or negligible effect on LDL concentration.

This difference has practical implications. Most standard fish oil capsules contain a mix of EPA and DHA, often in a roughly 60/40 or 50/50 ratio. If you’re taking fish oil and your LDL rises, the DHA component is the likelier culprit. Prescription EPA-only products (like icosapent ethyl) were developed in part to deliver triglyceride-lowering benefits with less LDL disruption. The distinction between EPA and DHA is not trivial: it has shaped how the pharmaceutical industry formulates omega-3 drugs and how cardiologists think about prescribing them.

Bigger LDL Particles May Tell a Different Story

When fish oil does raise LDL cholesterol, the increase often comes with a shift toward larger LDL particles. This matters because small, dense LDL particles are more strongly associated with artery damage than large, buoyant ones. In one study, LDL particles were significantly larger after fish oil supplementation compared to baseline, and this increase in size tracked inversely with triglyceride levels.⁸ The researchers concluded that the rise in LDL cholesterol reflected an increase in particle size that could actually be favorable from an atherosclerosis standpoint.

At higher doses, fish oil also reduced small, dense LDL specifically. One trial using about 3.4 grams per day of marine omega-3s found significant drops in apolipoprotein C-III and VLDL cholesterol.⁹ Meanwhile, fish oil reduced small, dense LDL by about 22% in subjects who already had an unfavorable lipid profile dominated by those particles.¹⁰

So a standard lipid panel showing higher LDL cholesterol after fish oil use doesn’t necessarily mean your cardiovascular risk went up. The number on the lab report went in the wrong direction, but the composition of the LDL particles may have shifted in a more favorable direction. That said, not every study finds this shift. In people with diabetes and high triglycerides, one trial found that LDL concentration rose in response to fish oil but the cholesterol-to-protein ratio in LDL particles didn’t change, suggesting particle size stayed the same.¹¹ The particle-size benefit is real in many people but isn’t guaranteed.

Your Genetics Influence the Response

One of the strongest predictors of whether fish oil will raise your LDL is your apolipoprotein E genotype. About a quarter of people carry at least one copy of the apoE4 variant, and these individuals appear particularly susceptible to LDL increases from DHA supplementation. In one trial, carriers of apoE4 saw a 10% increase in LDL cholesterol with high-dose DHA, while people with the more common apoE3/E3 genotype showed a non-significant decrease.¹² A separate study confirmed that apoE4 carriers experienced a significant increase in total cholesterol and a trend toward lower HDL when taking fish oil, relative to the common apoE3/E3 profile.¹³

The apoE4 allele is the same variant associated with higher Alzheimer’s risk, so many people are already aware of their status through genetic testing. If you carry apoE4 and are considering high-dose fish oil or DHA-rich supplements, monitoring your lipid levels is worth the effort. The researchers noted that the LDL increase in apoE4 carriers might partly negate the heart-protective benefits of DHA in this group.

What About HDL and the Overall Lipid Picture

While the LDL story is complicated, fish oil’s effects on HDL cholesterol are generally neutral or mildly positive. A 2024 trial in healthy young adults found that fish oil supplementation improved HDL function, specifically its ability to pull cholesterol out of cells. This cholesterol efflux capacity increased significantly and correlated with plasma EPA levels.¹⁴ In other words, even if HDL concentration doesn’t change much, the HDL particles may work better at their actual job after fish oil supplementation.

Fish oil also has meaningful effects on what happens after you eat a fatty meal. The spike in blood triglycerides that follows a high-fat meal (postprandial lipemia) is itself a cardiovascular risk factor, and chronic fish oil use blunts that spike. One study found that fish oil reduced post-meal triglyceride-rich particles by roughly 40%, likely by reducing the gut’s production of these particles rather than by speeding up their clearance.¹⁵ Similar results were observed in insulin-resistant obese men, where fish oil reduced the post-meal triglyceride response on its own.¹⁶

Fish Oil and Statins Together

Many people who worry about fish oil raising their cholesterol are already taking a statin. The good news is that the combination is generally safe and well tolerated. Across multiple small studies, adding omega-3s to a statin regimen provided additional lipid improvements without increasing the risk of muscle or liver side effects.¹⁷ The statin keeps LDL in check while the omega-3s address triglycerides, which statins are less effective at lowering.

However, even on a statin, DHA-rich fish oil can still nudge LDL upward. In patients already on statin therapy, DHA-rich fish oil at higher doses lowered triglycerides by about 27% but also tended to lower VLDL cholesterol while raising LDL cholesterol and apolipoprotein B within the LDL fraction.¹⁸ In a meta-analysis comparing statin-plus-omega-3 therapy to statins alone, LDL cholesterol levels were not significantly different between the two groups overall, though there were mixed results on plaque composition.¹⁹ So for most people on statins, adding fish oil won’t undo the statin’s LDL-lowering work, but it’s worth checking your numbers after starting.

The Big Clinical Trials Disagree on Heart Outcomes

If fish oil raises LDL but also lowers triglycerides and shifts LDL to a less harmful type, the real question is whether it actually helps or hurts the heart. Two landmark trials came to very different conclusions. The REDUCE-IT trial tested high-dose EPA alone (icosapent ethyl, four grams daily) and found a significant reduction in major cardiovascular events. But the STRENGTH trial tested a combination of EPA and DHA at similar total omega-3 doses and found no benefit at all.²⁰

In the STRENGTH trial, even patients who achieved the highest blood levels of EPA and DHA showed no improvement in cardiovascular outcomes compared to placebo. The event rate in the top third of EPA achievers was essentially identical to the placebo group.²¹ Researchers continue to debate why these trials diverged. Possible explanations include differences in the placebo used (mineral oil in REDUCE-IT, corn oil in STRENGTH), the absence of DHA in REDUCE-IT’s formulation, and potential non-lipid effects of EPA that DHA doesn’t share.

The divergence between these trials matters because it suggests that the LDL-raising effect of DHA may not be merely cosmetic. If DHA raises LDL and also fails to reduce cardiovascular events when paired with EPA, the LDL increase could be part of the reason a combined EPA-plus-DHA approach underperforms. This remains an active area of investigation.

Plant-Based Omega-3s and Cholesterol

People who are concerned about fish oil’s effect on LDL sometimes consider plant-based omega-3 sources like flaxseed oil, which is rich in alpha-linolenic acid (ALA) rather than EPA or DHA. The lipid effects are quite different. In a direct comparison, fish oil predictably lowered triglycerides and reduced small, dense LDL, while flaxseed oil did not reproduce those changes.¹⁰ A separate trial comparing fish oil, flaxseed oil, and hempseed oil found no significant differences in total cholesterol, HDL, LDL, or triglycerides across any of the groups.²²

The body converts ALA to EPA and DHA very inefficiently, which likely explains why plant-based omega-3s don’t replicate the triglyceride-lowering or the LDL-raising effects of fish oil. If your primary goal is lowering triglycerides, plant sources aren’t a substitute. But if you’re worried specifically about LDL going up, plant-based omega-3s won’t cause that problem, because they also won’t deliver enough EPA or DHA to meaningfully alter lipid metabolism.

Effects on Liver Fat Metabolism

Beyond what shows up in your blood work, fish oil influences how the liver handles fat at a deeper level. In animal studies of diet-induced fatty liver, fish oil corrected the expression of genes involved in fatty acid and cholesterol processing, including genes that control cholesterol production and excretion.²³ Rats fed a high-fat diet and given fish oil showed significant drops in liver and blood cholesterol, along with increased excretion of cholesterol through feces.²⁴ Even low doses of fish oil prevented the accumulation of triglycerides and cholesterol in the livers of mice fed a high-cholesterol diet, partly by boosting fecal cholesterol excretion.²⁵

These animal studies paint a picture that looks quite different from the human blood-test findings. In the liver itself, fish oil seems to improve cholesterol handling. The apparent contradiction dissolves when you remember the VLDL-to-LDL conversion issue: the liver may be producing and exporting less cholesterol overall, but the particles it does release are more likely to become LDL in the bloodstream rather than being cleared quickly. So the liver improves its own lipid health while the blood test looks worse. It’s a reminder that a single number on a lipid panel doesn’t capture everything happening in your body.

Who Should Actually Worry

For the average person taking a standard one-gram fish oil capsule for general health, the LDL increase is usually small enough to be clinically insignificant. The effect is dose-dependent: higher doses produce more noticeable LDL changes. The people most likely to see a meaningful bump in LDL are those taking prescription-strength omega-3 doses (two to four grams of EPA/DHA daily), those who start with high triglycerides, those taking DHA-heavy formulations, and those who carry the apoE4 genetic variant.

If you’re taking fish oil and notice your LDL has crept up, a few options exist. Switching from a mixed EPA/DHA product to an EPA-only formulation may solve the problem. Pairing fish oil with a statin can offset the LDL rise in most cases. And simply being aware that the increase likely reflects larger, less dangerous LDL particles gives useful context, though it doesn’t mean you should ignore the change entirely. A conversation with your doctor about advanced lipid testing, which measures particle number and size rather than just total cholesterol weight, can clarify whether the increase is genuinely concerning for you individually.